NeuroLeap
PrivateLast Round
Accelerator
Jan 10, 2022
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NeuroLeap operates in Healthcare & Life Sciences and is based in Mumbai. Its latest recorded funding round was an Accelerator round in January 2022.
NeuroLeap is a health technology company that provides brain assessment and enhancement services using non-invasive brain-computer interface technology.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Medical AI
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroLeap Comparables
Compare NeuroLeap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Peak Brain Institute | 82% | |
| Braincode Centers | 78% | |
| Brain Train Centers, Inc. | 76% |
For institutional investors. Book with your work email.
NeuroLeap Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 10, 2022 | ||||
| Angel | Oct 9, 2019 |
For institutional investors. Book with your work email.
NeuroLeap Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| N. S. Raghavan Centre for Entrepreneurial Learning | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 163% MoM, reaching 11.7K.
- Aug 22, 2026
Monthly visitors increased 214% MoM, reaching 4.4K.
For institutional investors. Book with your work email.
NeuroLeap Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroLeap's valuation, stock price, and market status.
Is NeuroLeap a public or private company?
NeuroLeap is a private company.
What is the current stock price of NeuroLeap?
NeuroLeap is a private company, so its shares have no public market price. Caplight tracks NeuroLeap's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroLeap worth (valuation)?
Valuation information for NeuroLeap is not publicly available.
Can I buy NeuroLeap stock?
NeuroLeap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroLeap's last funding round?
NeuroLeap's most recent funding round was Accelerator on January 10, 2022.
Who are the main investors in NeuroLeap?
Key investors in NeuroLeap include N. S. Raghavan Centre for Entrepreneurial Learning.
Will NeuroLeap IPO soon?
No public IPO plans have been announced for NeuroLeap.
How can I track NeuroLeap secondary market activity?
Caplight tracks bids, offers, and trades in NeuroLeap's shares on secondary markets.